Overview
New Advances
Facilities
Interactive Demo


In keeping with its commitment to the highest standard of cancer care, the Pacific Cancer Institute continues to provide the latest advances in technology at its multi-million dollar facilities.
Central to PCI's progressive approach is its use of the new Intensity Modulated Radiation Therapy (IMRT) system, the most precise and sophisticated cancer treatment in the world. PCI is among the first cancer centers in the nation and one of the few in Hawaii equipped to offer IMRT. To Learn more about this and other treatments we invite you to view our interactive technology demo. You'll need the Flash 5 plugin to view the demo.
View the Demo Get Flash 5

No time for the demo? Learn more about this and other treatments listed below.
Intensity Modulated Radiation Therapy | IMRT
IMRT is a revolutionary type of external beam treatment that is able to conform radiation to the size, shape and location of a tumor.
IMRT relies on two advanced technologies
• Inverse treatment planning - Through sophisticated algorithms, this system determines the best treatment plan, maximizing dose to tumor while minimizing exposure to surrounding healthy tissue.
• Multileaf collimator (MLC) - Following the inverse treatment plan, computer-controlled metal leaves adjust the shape of the radiation beam to the shape of the tumor, allowing the highest radiation dose to attack the cancer while shielding healthy tissue.
Benefits to Patients
Patients benefit from IMRT treatment through reduced complications which may be caused by radiation delivery and the increased probability of cure due to increased dose to the tumor. Patients appreciate the fact that this advanced therapy can be delivered in the same time required for a standard treatment. IMRT finally makes radiation therapy an option for treating types of cancer that may not have been otherwise treated, giving patients new hope for cure.
• IMRT is being used today to escalate the doses given to prostate cancer patients and the preliminary results indicate this increase in dose improves the probability of cure. A reduction in the complications associated with prostate therapy has also been reported.
• In other treatment sites such as breast and head-and-neck cancers, a reduction in the complications have also been reported.
• A great deal of the IMRT focus has been on cancers of the central nervous system, where positive results have been reported as well. Metastases are also shown to respond favorably to IMRT treatment.
IMRT is currently being used to treat cancer in the following sites:
• Prostate
• Breast
• Head & Neck
• Central Nervous System
• Lung
• Liver
• Recurrent tumors
|